Olmesartan Medoxomil 40mg + Amlodipine 5mg Tablets

Olmesartan Medoxomil 40mg + Amlodipine 5mg combines an angiotensin-receptor blocker with a calcium-channel blocker for high blood pressure. It lowers vascular resistance through two complementary pathways.
Take with or without food at a consistent daily time. Monitor pressure during the initial weeks and after strength changes. Do not take an extra combination tablet to adjust only one ingredient.
Olmesartan blocks angiotensin II-mediated constriction, while amlodipine limits calcium entry into arterial smooth muscle. Both actions relax blood vessels and reduce blood pressure.
Ankle swelling, headache, flushing, dizziness and low blood pressure can occur. Severe faintness, facial swelling or markedly reduced urination needs prompt assessment.
Pregnancy is excluded because of olmesartan's fetal-harm risk. Kidney function and potassium need monitoring. Severe aortic stenosis or marked hypotension affects tolerability. NSAIDs, potassium supplements and other antihypertensives can change the treatment balance.
Provides complementary blood-vessel relaxation for sustained control when one agent alone is insufficient.
Yes. Amlodipine can cause peripheral oedema through local vascular effects; the cause should be assessed rather than assumed.
No. This two-drug formulation contains an ARB and a calcium-channel blocker, not hydrochlorothiazide or chlorthalidone.
No. It is regular blood-pressure treatment, not a rapid-relief angina medicine.
Olmesartan affects renal blood-flow regulation and potassium handling, particularly with dehydration or renal disease.
No. The dose of each component matters, so both ingredient amounts must match the intended regimen.
Calcium-channel blocker: a medicine that relaxes arterial smooth muscle. ARB: an angiotensin-receptor blocker. Peripheral oedema: swelling around the extremities. Vascular resistance: opposition to blood flow through vessels; AR: Olmesartan Medoxomil 40mg + Amlodipine 5mg أقراص; FR: Olmesartan Medoxomil 40mg + Amlodipine 5mg comprimés; PT: Olmesartan Medoxomil 40mg + Amlodipine 5mg comprimidos; ES: Olmesartan Medoxomil 40mg + Amlodipine 5mg comprimidos; RU: Olmesartan Medoxomil 40mg + Amlodipine 5mg таблетки; ID: Olmesartan Medoxomil 40mg + Amlodipine 5mg tablet; VI: Olmesartan Medoxomil 40mg + Amlodipine 5mg viên nén; MS: Olmesartan Medoxomil 40mg + Amlodipine 5mg tablet; TL: Olmesartan Medoxomil 40mg + Amlodipine 5mg tableta; ZH-SG: Olmesartan Medoxomil 40mg + Amlodipine 5mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Olmesartan Medoxomil 40mg + Amlodipine 5mg Tablets under Cardiac Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Olmesartan Medoxomil 40mg + Amlodipine 5mg Tablets